Related Experiment Videos

c-FLIP efficiently rescues TRAF-2-/- cells from TNF-induced apoptosis

C Guiet1, E Silvestri, E De Smaele

  • 1Basel Institute for Immunology, Grenzacherstrasse 487, Postfach CH-4005, Basel, Switzerland.

Cell Death and Differentiation
|February 13, 2002
PubMed

Insights

Tumor Necrosis Factor alpha (TNF) resistance in cells is linked to reduced levels of the anti-apoptotic molecule c-FLIP. Restoring c-FLIP levels can reverse this resistance, offering therapeutic potential.

Area of Science:

  • Cellular biology
  • Immunology
  • Molecular mechanisms of cell death

Background:

  • Tumor Necrosis Factor alpha (TNF) typically fails to induce apoptosis due to cellular resistance mechanisms.
  • Cytoprotective responses are known to mediate resistance to TNF's cytotoxic activity.

Purpose of the Study:

  • To investigate the molecular basis of TNF resistance in cells lacking TRAF-2.
  • To determine the role of c-FLIP in mediating resistance to TNF-induced apoptosis.

Main Methods:

  • Utilized TRAF-2-/- embryonic fibroblasts (EF).
  • Assessed levels and degradation of the anti-apoptotic molecule c-FLIP.
  • Performed reconstitution experiments by reintroducing c-FLIP into TRAF-2-/- EF.

Main Results:

  • TRAF-2-/- EF exhibited significantly reduced levels of c-FLIP due to enhanced protein degradation.
  • Restoring c-FLIP levels in TRAF-2-/- EF was sufficient to confer resistance to TNF toxicity.
  • Confirmed the essential role of c-FLIP in cellular protection against TNF.

Conclusions:

  • c-FLIP plays a critical role in protecting cells from the cytotoxic effects of TNF.
  • The degradation of c-FLIP contributes to TNF resistance in TRAF-2 deficient cells.
  • Findings have implications for developing treatments for inflammatory and proliferative disorders.

Related Concept Videos